Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
22 April, 2021 08:48 IST
Buy HDFC Bank; target price of Rs 1,740: IDBI Capital
Source: IRIS | 19 Jan, 2021, 04.59PM
Rating: NAN / 5 stars.
Comments  |  Post Comment

 HDFC Bank's Proforma GNPA remained stable at 1.38% vs 1.37% QoQ while NNPA at 0.4%; reported GNPA declined to further 0.81%. However, Proforma Slippages remain at 1.86% vs 2.31% YoY vs 1.98% QoQ. Restructuring under RBI resolution framework stood at 0.5% of advances incl. fewer corporate cases.

Bank reported collection efficiency at 97% in December month (earlier 95% Sept month). Profitability (PBT growth) saw an uptick led by lower provision; PAT remain stable at 18%. NII grew by 15% YoY against a loan growth of 16% YoY. PPoP grew by 17% YoY as cost to income ratio improved (36% vs 38% YoY); fee income grew by 10% YoY vs -3% (Q2FY21).

Commenting on the Q3 earnings review, the broking firm IDBI Capital Markets & Securities said, "As overall economy continues to improve, we believe that HDFCB would see the best revival in growth within the sector."

IDBI Capital re-iterates 'Buy' with a new TP of Rs.1,740 (earlier Rs.1,430) based on P/Bv of 3.6x (earlier 3.1X) FY23E as clarity emerges on impact of Covid -19 on asset quality front.

"HDFC Bank continues to command highest market share amongst private banks. We believe HDFCB to traverse through these tough times and will gain market share led by strong leadership position across segments, large distribution, digital focus and strong capital adequacy. We remain structurally positive on HDFCB given its superior credit underwriting, structurally better NIM and the ability to maintain higher RoA among its peers," it added.

Disclaimer: IRIS has taken due care and caution in compilation of data for its web site. Information has been obtained by IRIS from sources which it considers reliable. However, IRIS does not guarantee the accuracy, adequacy or completeness of any information and is not responsible for any errors or omissions or for the results obtained from the use of such information. IRIS especially states that it has no financial liability whatsoever to any user on account of the use of information provided on its website.

 



 Post Comment
Name Email
Comment
Security Code type    into this box
Related Articles
IDBI Capital maintains Buy on HDFC Bank with target price of Rs 1,740 - 21-Apr-2021 15:13
Prestige Estates Projects acquires stake in two partnership firm - 21-Apr-2021 14:55
Jubilant Pharmova arm completes studies using novel oral formulation of Remdesivir - 21-Apr-2021 14:26
Mahindra Treo Zor crosses 1,000 sales milestone - 21-Apr-2021 13:23
Accumulate Infosys; target price of Rs 1,505: IDBI Capital - 21-Apr-2021 12:49
Accumulate ACC; target price of Rs 2,143: IDBI Capital - 21-Apr-2021 11:31
IDBI Capital maintains Hold on Nestle with target price of Rs 16,195 - 21-Apr-2021 11:19
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer